News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
177,531 Results
Type
Article (7263)
Company Profile (63)
Press Release (170204)
Multimedia
Podcasts (3)
Webinars (1)
Section
Business (53689)
Career Advice (212)
Deals (9067)
Drug Delivery (9)
Drug Development (24631)
Employer Resources (22)
FDA (4230)
Job Trends (4196)
News (89541)
Policy (7317)
Tag
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
Academia (503)
Accelerated approval (11)
Adcomms (2)
Allergies (60)
Alliances (7580)
ALS (78)
Alzheimer's disease (657)
Antibody-drug conjugate (ADC) (138)
Approvals (4563)
Artificial intelligence (221)
Autoimmune disease (75)
Automation (21)
Bankruptcy (48)
Best Places to Work (3962)
BIOSECURE Act (4)
Biosimilars (80)
Biotechnology (33)
Bladder cancer (112)
Brain cancer (23)
Breast cancer (351)
Cancer (2385)
Cardiovascular disease (193)
Career advice (193)
Career pathing (10)
CAR-T (89)
CDC (6)
Cell therapy (253)
Cervical cancer (21)
Clinical research (23301)
Collaboration (728)
Company closure (2)
Compensation (465)
Complete response letters (13)
COVID-19 (940)
CRISPR (36)
C-suite (315)
Cystic fibrosis (64)
Data (3311)
Depression (47)
Diabetes (202)
Diagnostics (1923)
Digital health (22)
Diversity (2)
Diversity, equity & inclusion (5)
Drug discovery (96)
Drug pricing (25)
Drug shortages (4)
Duchenne muscular dystrophy (107)
Earnings (41389)
Editorial (9)
Employer branding (2)
Employer resources (23)
Events (28818)
Executive appointments (414)
FDA (5846)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (10)
Funding (622)
Gene editing (72)
Generative AI (11)
Gene therapy (215)
GLP-1 (344)
Government (1310)
Grass and pollen (3)
Guidances (327)
Healthcare (5716)
HIV (37)
Huntington's disease (23)
IgA nephropathy (47)
Immunology and inflammation (77)
Immuno-oncology (19)
Indications (49)
Infectious disease (1053)
Inflammatory bowel disease (61)
Inflation Reduction Act (2)
Influenza (43)
Intellectual property (71)
Interviews (40)
IPO (5765)
IRA (3)
Job creations (538)
Job search strategy (152)
JPM (6)
Kidney cancer (8)
Labor market (25)
Layoffs (105)
Leadership (4)
Legal (1193)
Liver cancer (35)
Longevity (5)
Lung cancer (349)
Lymphoma (225)
Machine learning (19)
Management (7)
Manufacturing (270)
MASH (100)
Medical device (3947)
Medtech (3965)
Mergers & acquisitions (3799)
Metabolic disorders (510)
Multiple sclerosis (90)
NASH (10)
Neurodegenerative disease (130)
Neuropsychiatric disorders (28)
Neuroscience (1167)
NextGen: Class of 2026 (1265)
Non-profit (1062)
Now hiring (4)
Obesity (204)
Opinion (21)
Ovarian cancer (71)
Pain (67)
Pancreatic cancer (93)
Parkinson's disease (111)
Partnered (6)
Patents (133)
Patient recruitment (192)
Peanut (27)
People (8360)
Pharmaceutical (14)
Pharmacy benefit managers (7)
Phase 1 (6095)
Phase 2 (9904)
Phase 3 (9183)
Pipeline (3036)
Policy (21)
Postmarket research (862)
Preclinical (1957)
Press Release (16)
Prostate cancer (130)
Psychedelics (4)
Radiopharmaceuticals (75)
Rare diseases (311)
Real estate (889)
Recruiting (14)
Regulatory (6495)
Reports (18)
Research institute (519)
Resumes & cover letters (18)
Rett syndrome (19)
RNA editing (4)
RSV (43)
Schizophrenia (56)
Series A (90)
Series B (79)
Sickle cell disease (41)
Special edition (11)
Spinal muscular atrophy (62)
Sponsored (8)
Startups (481)
Stomach cancer (2)
Supply chain (40)
Tariffs (12)
The Weekly (3)
Vaccines (362)
Venture capital (21)
Weight loss (132)
Women's health (37)
Worklife (6)
Date
Today (46)
Last 7 days (241)
Last 30 days (836)
Last 365 days (14716)
2026 (1209)
2025 (14992)
2024 (12051)
2023 (10779)
2022 (22611)
2021 (20163)
2020 (12692)
2019 (10292)
2018 (7758)
2017 (7126)
2016 (5759)
2015 (7553)
2014 (5327)
2013 (3782)
2012 (4524)
2011 (4663)
2010 (4260)
Location
Africa (133)
Alabama (21)
Alaska (2)
Arizona (60)
Arkansas (4)
Asia (10600)
Australia (1437)
California (5360)
Canada (1295)
China (414)
Colorado (212)
Connecticut (291)
Delaware (221)
Europe (24834)
Florida (564)
Georgia (141)
Hawaii (4)
Idaho (14)
Illinois (431)
India (28)
Indiana (225)
Iowa (9)
Japan (282)
Kansas (24)
Kentucky (13)
Louisiana (13)
Maine (32)
Maryland (630)
Massachusetts (3891)
Michigan (103)
Minnesota (311)
Mississippi (2)
Missouri (58)
Montana (7)
Nebraska (3)
Nevada (62)
New Hampshire (23)
New Jersey (1545)
New Mexico (7)
New York (1308)
North Carolina (524)
North Dakota (1)
Northern California (2609)
Ohio (125)
Oklahoma (5)
Oregon (15)
Pennsylvania (865)
Puerto Rico (9)
Rhode Island (14)
South America (191)
South Carolina (10)
Southern California (2051)
Tennessee (74)
Texas (786)
United States (18202)
Utah (104)
Virginia (133)
Washington D.C. (27)
Washington State (445)
West Virginia (2)
Wisconsin (89)
Wyoming (1)
177,531 Results for "24".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AbCellera to Report Full Year 2025 Financial Results on February 24, 2026
January 23, 2026
·
1 min read
Press Releases
Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
February 10, 2026
·
1 min read
Press Releases
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
February 10, 2026
·
1 min read
Mergers & acquisitions
Eli Lilly Enters CAR T Realm With $2.4B Orna Buy, Starting With Autoimmune
The deal gets Lilly access to Orna’s in vivo CAR T technology. The biotech’s lead asset, which has yet to start clinical testing, is focused on B cell–driven autoimmune diseases.
February 9, 2026
·
2 min read
·
Dan Samorodnitsky
Press Releases
Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results
February 10, 2026
·
1 min read
Press Releases
Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months
December 24, 2025
·
3 min read
Press Releases
Henry Schein to Webcast Fourth Quarter 2025 Conference Call on Tuesday, February 24, 2026, at 8:00 A.M. ET
January 22, 2026
·
2 min read
Press Releases
Antheia Raises Additional $24 Million to Complete Series C Financing, Bringing Total Funds Raised to More than $175 Million Over Past Year
January 28, 2026
·
2 min read
Press Releases
Anti-hypertensive Drugs Market Size to Hit USD 37.24 Billion by 2034
November 17, 2025
·
1 min read
Press Releases
Antifungal Drugs Market Size to Worth USD 24.25 Billion by 2034
November 5, 2025
·
1 min read
1 of 17,754
Next
